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ABSTRACT
Studies of the Respiratory Chain of Methylococcus capsulatus (Bath)
Timothy Brian Miley
The methanotrophic bacterium, Methylococcus capsulatus, is capable of the
conversion of methane to methanol at ambient temperature and pressure.  In this
manuscript, we show that quinols can provide reducing equivalents to the membrane-
bound form of methane monooxygenase (pMMO), substituting for NADH in whole cells
and membrane fractions.  Additionally, quinols are shown to be effective reductants for
the detergent-solubilized enzyme, whereas NADH is ineffective.  The decyl-analog of
plastoquinol and duroquinol provide the greatest MMO activity in whole cells and
membrane fractions, as well as detergent-solubilized samples.  Lauryl maltoside is by far
the best detergent for solubilization of catalytically-active methane monooxygenase.
This detergent was also utilized when reincorporating the endogenous quinone, 18’-
methylene CoQ8, during analysis of pMMO enzymatic activity supported by endogenous
quinones.  The endogenous quinone was capable of supporting activity of pMMO in
detergent-solubilized fractions, when used in combination with NADH.  However, the
synthetically reduced form of the endogenous quinone is incapable of supporting activity
in whole cells, membranes, or the solubilized fraction.  Finally, oxygen uptake studies of
whole cells, membranes, and solubilized membranes in addition to UV-visible
spectroscopic studies reveal the existence of an alternative oxidase in vitro.  The
inhibitors octyl gallate and cyanide inhibit oxygen uptake in both membranes and whole
cells.
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1CHAPTER ONE
Introduction
2Methylotrophs
 Methylotrophs are a diverse group of eubacteria that utilize reduced carbon
substrates possessing no carbon-carbon bonds as their sole source of carbon and energy
(5).  More specifically, this includes bacteria which can utilize methane, methanol,
methylated amines, or methylated sulfur compounds as their substrates for growth.  Most
methylotrophs studied are gram-negative and obligately methylotrophic, but gram
positive species have been described.  Also, a variety of facultative organisms are known
which are capable of growing on either one-carbon compounds or multi-carbon
compounds.  Many methylotrophs are aerobic while a few are anaerobic (32).
Furthermore, methylotrophs are widespread throughout nature, existing at various
interfaces where both oxygen (aerobic) and carbon sources are both plentiful (27) such as
soils, groundwater, oceans and freshwater sediments (62).
Methanotrophs
Methanotrophs are a diverse group of organisms comprising several genera and
perhaps more than one family (37).  These organisms use methane as their sole source of
both carbon and energy (6,37).  Methanotrophs reside in the family Methylococcaceae
and include gram-negative rods, vibrio, and cocci (26).  They are strictly aerobic, are
catalase and cytochrome c oxidase positive, and possess cytochromes c, a and o or b (26).
They are quite widespread in nature, existing in soil, fresh water or marine environments
and have been identified in symbiotic relationships with marine bivalves (2).  All strains
also possess a complex arrangement of intracytoplasmic membranes (57) when grown on
methane (37) (Figure 1).  Members of this group also have the ability to form exospores,
cysts, or lipid cysts during resting stage (27,37).  Additionally, methanotrophic bacteria
3Figure 1
Electron micrograph of Methylococcus capsulatus magnified 50,000X detailing the
intracytoplasmic membranes indicative of pMMO expression.
4are a vital part of the global carbon cycle, representing the primary means for the
production of carbon dioxide from methane, an end product of anaerobic fermentation
(26).  In some aquatic environments they are found at certain times of the year within a
very restricted range of depths, where methane discharged from anaerobic degradation
and dissolved oxygen are at levels optimal for their growth.
Methane-utilizing bacteria have been split into two broad groups designated Type
I and Type II, on the basis of their carbon assimilation pathways, and on the arrangement
of their intracytoplasmic membranes (6,57).  The carbon assimilation pathways consist of
the ribulose monophosphate (RuMP) pathway and the serine pathway.  Type I
methanotrophs are characterized by the former pathway, while Type II methanotrophs
utilize the latter (6,15).  The organism under study in this laboratory for the past nine
years, Methylococcus capsulatus (Bath), is capable of nitrogen fixation but prefers
nitrates as its source of nitrogen (37).  M. capsulatus is unique in that it contains both a
RuMP pathway as well as a serine pathway, and it is also capable of autotrophic carbon
dioxide fixation via the Calvin-Benson cycle (27,63).  Due to these complexities, one of
the major groups was further subdivided to accommodate this unique prokaryote and
designated Type X.  It is one of only a handful of methanotrophs isolated and described
in the literature before 1970.  Methylococcus capsulatus will be the focus of the research
described here.
5The MMO System and Methylococcus capsulatus
The bioenergetics and metabolism of methanotrophs hinge on the methane
monooxygenase (MMO) system.  It is now known that two forms of this enzyme exist.
There is a particulate (membrane-bound) form, or pMMO, as well as a soluble (sMMO)
form.  The two forms are not expressed at the same time during growth.  Consequently,
the environmental growth conditions dictate which form is expressed at any given time
(23,45,57).  The soluble form of the enzyme is expressed at high cell density and
relatively low copper concentrations, and further stimulated by iron (22).  Additionally,
the gene cluster for sMMO from M. capsulatus has been shown to be transcriptionally
repressed in vitro by the presence of copper ions (39).  Conversely, methanotrophic
bacteria grown to normal cell densities (2-5g/L) express only pMMO, and this is further
enhanced by the presence of copper (24,57) (Figure 2).  It appears that only three
methanotroph strains can express the soluble form.  Therefore, the particulate form is
believed to be the most prevalent in nature.  Even though the two forms of the enzyme
catalyze the same reaction, they are functionally different.  The soluble MMO can
oxidize cyclic and aromatic compounds, whereas pMMO can oxidize alkanes and alkenes
only up to four carbons in length and will not oxidize cyclic or aromatic compounds (15).
The soluble form of the enzyme has been purified from Type II methanotrophs as
well as M. capsulatus (22).  The sMMO from M. capsulatus (Bath) is the most
thoroughly studied and best characterized at this point.  It consists of three separate
components known as A, B, and C.  Component A is a hydroxylase (MMOH) and
consists of three subunits with molecular weights of 17kD, 42kD, and 54 kD.  The
arrangement of these subunits is of an α2β2γ2 stoichiometry.  Crystallographic
6Figure 2
Typical growth curve for a culture of Methylococcus capsulatus following transfer to the
fermentation vessel.  Copper and iron salts were added at the time point indicated.  This
particular batch was the initial batch of three grown succesively from one inoculation.
Typical growth rates for batches inoculated with small amount of initial batch are
approximately two-fold faster.
7characterization of the enzyme demonstrated the presence of a µ-oxo bridged iron cluster
in the active site of the hydroxylase, with binuclear iron active sites found in each α
subunit (22).
Both forms of MMO are irreversibly inhibited by acetylene (9,45) and both are
also inhibited by the oxygen analogs azide and cyanide (9).  The membrane-bound form
is also inhibited by metal chelators such as EDTA and dithiocarbamates whereas sMMO
shows no inhibitory effects due to the presence of these compounds (6,9).  This suggests
that the putative metal center(s) of pMMO are not tightly bound.
Transient kinetics have been utilized to detect several reactive oxygen
intermediates during oxygen activation by sMMO (30).  The fully reduced diferrous state
of the enzyme exhibits an EPR signal of g = 16 (22).  This signal disappears upon
addition of oxygen with a rate constant of 22 s-1.  The decay results in the formation of an
EPR silent compound Q, which absorbs in the UV-Vis range at 330 and 430 nm.  Results
from both EXAFS and Mossbauer spectroscopy have suggested that the Q intermediate is
an FeIVO2 diamond core structure (52)
Component B (MMOB) is a relatively small protein apparently absent of
cofactors.  Recently published investigations have suggested that MMOB plays a
regulatory role in the sMMO mechanism.  When MMOB is present, v0 (methane
oxidation) is increased up to 150-fold (23).  Published reports utilizing the MMO from
Methylosinus trichosporium OB3b have shown that MMOB causes a –132 mV shift in
the midpoint potential of MMOH as measured by both EPR and Mossbauer spectroscopy.
This seems to suggest that the B subunit binds approximately 10,000-fold more strongly
to the diferric state of MMOH than to the diferrous state (42).  Recent EPR evidence
8shows that this change in midpoint potential is related to a change in the conformation of
the monooxygenase diiron cluster (17).  The conformational change is related to a
concomitant protonation of a bridging µ-hydroxyl ligand.  This results in weakening of
the bond and release of a bridging water ligand from the diferrous MMOH, thus allowing
oxygen binding and activation.
Component C of sMMO (MMOR) contains Fe-S clusters as well as a flavin.  It
mediates electron flow from the reductant (intracellular NADH) to MMOH (9).
The gene for the hydroxylase component of sMMO has been cloned from M.
capsulatus (Bath) (54,55).  Additionally, hybridization experiments have been performed
with cDNA libraries from various methanotrophs.  Positive hybridizations have been
observed with only M. capsulatus and two strains of Methylosinus (56).  This provides
evidence that the sMMO and pMMO are products of separate genes, and that pMMO is
the more prevalent of the two.
The entire gene for the sMMO complex has been sequenced and all of the genes
for sMMO have been located in one cluster (operon) in both Methylosinus trichosporium
OB3b (12) and M. capsulatus (54,55).  The order of the cluster is mmoX, mmoY, mmoB,
mmoZ, orfY and mmoC.  The mmoX, mmoY, and mmoZ genes encode the α, β, and γ
subunits of MMOH, respectively.  Conversely, mmoB and mmoC encode the MMOB
and MMOC peptides.  The open reading frame orf Y serves no known function.
In contrast to the soluble form of methane monooxygenase, the particulate form is
less well-characterized.  It has yet to be reproducibly purified in an active form; this is
primarily due to the lability of the enzyme.  Many laboratories report enzyme inactivation
upon cell lysis (H. Dalton, personal communication; J. Lipscomb, personal
9communication; M. Donelly, personal communication).  Additionally, when pMMO
activity is stabilized in vitro, solubilization by most detergents results in loss of activity.
There have been four reports, thus far, in the literature claiming purification of
pMMO and they differ, somewhat in the methods utilized (1,58,66).  However, we and
others have been unable to reproduce the results of the earlier two, while the latter two
result in purification of a largely inactive protein.  Overall, the purification schemes for
pMMO are, at best, doubtful.
The most reliable information on pMMO has been gained via membrane
suspensions, cell extracts, or whole cells.  It has been shown that copper stabilizes and
increases the activity of pMMO in membrane fractions (38,46,57).  Without exogenous
copper, the stability of pMMO activity decreases markedly following cell lysis.
However, if the lysis buffer is supplemented with copper, pMMO can retain its activity
for several weeks (38).
There have also been previous reports of the appearance of three novel
polypeptides on SDS-PAGE following the expression of pMMO.  These polypeptides are
not present when the soluble form of methane monooxygenase is expressed.  These three
polypeptides have apparent molecular weights of 46kD, 35kD, and 26kD (46,57).  The
26kD protein is specifically labeled upon exposure to 14[C]-acetylene due to the fact that
acetylene is a suicide substrate for MMO.  Therefore, the 26kD polypeptide is presumed
to contain the substrate-oxidation site of pMMO.  Acetylene achieves similar inhibition
with cytochrome P450 by binding to the heme at its substrate-oxidation site (41).
A cDNA probe has been made to the 45kD peptide and has been used to screen
for pMMO genes in several strains (50).  From these studies, it has been discovered that
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the 26kD polypeptide gene lies upstream of the gene for the 45kD polypeptide.  Also,
these genes have been shown to be similar to the amoB and amoA genes of ammonia
monoxygenase.  These genes in AMO express similar molecular weight polypeptides.
Finally, AMO is also stabilized by copper addition, inhibited by acetylene and contains a
subunit irreversibly labeled by this acetylene (the molecular weight of this subunit is
27kD) (21).
This laboratory, as well as others, has reported that the enzymatic activity of
pMMO is stimulated by the addition of exogenous copper.  At present, the two most
likely explanations concerning this effect are: (1) copper causes more pMMO to be
produced at a transcriptional level, possibly due to activation of associated transcription
factors, and (2) inactive forms are constituitively present in the membrane but lack the
copper cofactor required for activity.  Although the effects controlling the differential
expression of the two forms of the enzyme are not clear, it appears that low
concentrations of copper are sufficient to both repress sMMO expression and intensify
pMMO expression.  The expression of the soluble form can be achieved only at higher
biomass, when copper concentration is insufficient for pMMO expression.  This
laboratory, as well as others, has found that copper is also required to maintain the
activity of pMMO in vitro (38,46,57).  Cell lysis in a copper-deficient medium leads to
dilution of the intracellular copper and rapid loss of pMMO activity.  However, by adding
copper, active pMMO is regenerated resulting in an increase in specific activity in vitro.
Thus, the following equilibrium can be used to describe this phenomenon:
   Holo-pMMO –nCu2+ (active) !" apo-pMMO (inactive)  +  nCu++
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Thus, the addition of excess copper ions to the cell extracts displaces the equilibrium to
the left, resulting in the production of more active holoenzyme.  Cook and Shiemke
(1996) provided evidence in support of this hypothesis by using acetylene as a probe of
the active site of pMMO (16).  Increased concentrations of exogenous copper led to
increasing amounts of radiolabeled 26kDa peptide after exposure to 14C-acetylene;
suggesting copper ions activate pMMO by regenerating the active form of the enzyme.
Until recently, NADH has been the only reductant known to provide reducing
equivalents to pMMO in vitro (9,53).  On the other hand, NADH cannot serve as a
reductant in whole cell preparations, because it cannot cross the membrane.  Formate,
however, can cross the lipid membrane and provide reducing energy for pMMO.  This
suggests that pMMO may not receive its reducing equivalents directly from NADH in
vivo.  It has been suggested that such reducing equivalents may come from the oxidation
of methanol by methanol dehydrogenase and that the electrons may be transferred along
an electron transport chain in an indirect fashion to pMMO (9), although evidence for this
is inconclusive.
Project Overview
A report from this laboratory recently demonstrated that pMMO could be reduced
by quinols (16).  In these experiments, pMMO was solubilized with detergent (lauryl
maltoside) and an array of quinols was examined for their ability to reduce pMMO in the
absence of NADH.  It is surmised that the requirement of pMMO for quinols is
responsible for previously reported purifications not being reproducible.  If pMMO
reduction by NADH were mediated by other proteins, then purification of pMMO would
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require that these components be present throughout the purification, as well.  However,
if quinones were used as a direct source of reducing equivalents, pMMO purification
would require fewer protein components for reconstitution of activity.  The latest
published purification of pMMO seems to support this theory (Nguyen, H. (1997)) and
this discussion will be elaborated by further work outlined in this dissertation.
Assuming that quinols serve to reduce pMMO directly, then it is necessary that an
enzyme transfer reducing equivalents from NADH to the quinone prior to reduction of
pMMO.  Such an enzyme was recently purified by Cook (1997) and shown to be an
NADH:quinone oxidoreductase (NDH) of type 2 (16).  No evidence for the existence of a
Complex I was observed, supporting the hypothesis that NADH reduces quinones via this
type 2 NDH and that these quinols may then reduce pMMO.
To investigate the respiratory chain of M. capsulatus and the apparent
involvement of pMMO this document will concentrate on key areas yet to be studied.
Our initial model suggests that reducing equivalents from NADH are transferred to the
quinone pool via the type-2 NDH.  This process is somewhat analogous to those
occurring in many bacteria as well as in mitochondria (3,4,7,10).  Subsequently, the
quinone pool would then partition between a putative bc1-like complex (10,15,28,59,60)
and pMMO, capable of reducing either enzyme complex.  The methanol produced by
pMMO would then be oxidized by methanol dehydrogenase (20) and reducing
equivalents from this reaction could be passed to a cytochrome c (43) with subsequent
reduction of a terminal oxidase (8,11,13,35).
To study some of these interactions, the following areas were investigated.  The
quinone pool was extracted and analyzed in order to examine their ability to reduce
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pMMO.  Additionally, the electron transfer chain was studied to determine how reducing
equivalents partition between pMMO and either the putative bc1-like complex or terminal
oxidase(s).  Bacteria as well as plants sometimes contain an alternative oxidase
(3,19,33,36,47), so this data would be instramental in elucidating the respiratory chain of
this bacterium.
Thus, the overall goal of this project was to serve as a foundation for further
research into the bioenergetics and respiratory chain of Methylococcus capsulatus (Bath).
With prior work on mitochondrial, bacterial, and plant systems serving as a reference
point, experiments within this project were performed in hopes that results would yield
clues to the interplay of proteins/lipids within the respiratory chain.
14
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CHAPTER TWO
Methods and Materials
24
Bacterial Growth (Methanotrophs)
Methylococcus capsulatus (Bath) were grown in Nitrate Salts Medium (NMS) as
described by Dalton and Whittenbury (1981).  Phosphate buffer (pH 6.8), Staley’s
vitamins (5), and CuSO4 at varying concentrations were also added.  To some cultures,
iron (both in the +2 and +3 oxidation states) was added as described by DiSpirito, et al.
(1996).  M. capsulatus were maintained on 1.8% agar plates containing 2µM CuSO4 at
37°C in a 20% methane, 80% air environment.  Large-scale growth was initiated in 250-
mL flasks containing 50 mL NMS with 2µM CuSO4.  These cultures were shaken at
45°C  for approximately two days and supplemented with methane in air daily.  Each
culture was transferred to a 2-L flask containing 500mL NMS, 10 µM CuSO4, and iron,
and maintained under the same conditions for two days.  After this period, the cultures
(typically 2 liters total) were used to inoculate nine liters of NMS containing 20µM
CuSO4 in a 14-L fermentor (New Brunswick Scientific) with the addition of 10 to 20µM
ferric and ferrous salts.  The fermentor was maintained at 45°C with continual stirring
and sparged with 20% methane in air, at a flow rate of approximately 2 SCFH.
Following a two to three day incubation period, the cells were harvested via
centrifugation at 4000xg, and the bacterial pellet was washed once and resuspended in ~
150mL 10mM PIPES, pH 7.0 (Fisher, Enzyme Grade).  This cell suspension was stored
in a septum-sealed vial at 4°C under an argon atmosphere until used.
Cell Lysis and Membrane Isolation
Bacteria were lysed by passing an aliquot of the cell suspension through a French
Pressure cell (SLM Aminco) at 18,000-20,000 psi.  Prior to lysis, cells were
supplemented with DNase I (Sigma, 40µg/mL).  Varying concentrations of CuSO4 were
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added when pMMO activity was to be measured, but copper was omitted when oxidase
activity was investigated.  The cell lysate was centrifuged at 31,000xg for 5-8 minutes to
remove cell debris and unbroken cells, and then centrifuged at 106,000xg for 90’ to pellet
the membrane.  The membrane pellet was resuspended in 10mM PIPES, pH 7.0 with a
Dounce homogenizer.  Membrane suspensions used for pMMO activity were again
supplemented with CuSO4, whereas membranes used for oxidase activity and
spectroscopic kinetics were not.
Enzymatic Activity Assays (pMMO Membrane Samples)
The pMMO activity was measured according to the previously published
propene-oxidation assay (2) at room temperature (except for Chapter IV, where 45°C was
used).  The assay was initiated by addition of 1 mL propene to 6-mL sealed serum vials
containing the particulate fraction, 5mM NADH (Sigma), 10mM PIPES (pH, 7.0,
Enzyme Grade, Fisher), and variable concentrations of CuSO4 (added exogenously).  The
liquid volume was held constant at 1.0 mL.  The NADH was lyophilized such that the
ethanol (present as a contaminant) was removed before stock solutions were prepared.  In
assays employing whole cells, 5mM formate (sodium salt) was utilized as the source of
reducing equivalents (1).  The concentration of propene oxide produced by pMMO was
measured by gas chromotography (SRI 8610 GC, equipped with an FID).  Enzyme
activity, in nmol/min, was determined from the slope of the linear portion of a graph of
propene oxide concentration versus time.  To calculate specific activity, the protein
concentrations were measured using the bicinchoninic acid assay (Pierce Biochemical)
(6) and bovine serum albumin (Sigma) as the standard.  Membrane suspensions were
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typically assayed at concentrations of 1.25 to 2.25 mg/mL total protein, while whole cell
suspensions were typically assayed at concentrations of 3.75 to 10 mg/mL total protein.
Detergent-solubilized pMMO Activity Assays
Enzymatic activity for the detergent-solubilized pMMO was analyzed as
mentioned above, except that quinones plus NADH, or quinols (without NADH present)
were added as the reducing system.  Both quinones and quinols were added as solids to
prevent interference from organic solvents (i.e., methanol, ethanol, and DMSO) in the gas
chromatogram.  A volume of stock solution containing 0.1 to 10 !moles of quinone (or
quinol) was delivered to the sealed serum vial, and the volatile organic solvent was
subsequently removed by heating to 55!C under vacuum.  The vial was then opened to
allow delivery of the sample components.  The vial was then sealed and 1 mL of propene
was added to initiate the reaction.  The concentration of propene oxide was measured as
described above.
Preparation of Quinols
2,3-Dimethylhydroquinol, trimethylhydoquinol, and menaquinone were
purchased from Aldrich Chemical Company while tetramethyl-p-benzoquinone
(duroquinone), 2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone (decyl-ubiquinone),
and decyl-plastoquinone were purchased from Sigma Chemical Company.  All six
quinones were used without further purification.  Quinones were reduced by the method
of Rich (5), or by small additions of dithionite/sodium borohydride followed by
extraction (3X) into an ether layer in a small test tube or acidification/precipitation by
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addition of 1N HCl.  The quinols were stored in acidified ethanol in a septum-sealed
serum vial under an argon atmosphere, at –20 to -70!C.  Concentrations of the quinol
solutions were determined based on their absorbances in conjunction with applicable
absorbtivity coefficients (decyl-plastoquinol, ε290 = 3450 M-1cm-1; duroquinol, ε283
=2140 M-1cm-1; decyl-ubiquinol, ε283 = 4100 M
-1cm-1; trimethylquinol, ε290 = 2050 M
-
1cm-1; 2,3-dimethylquinol, ε300 = 3980 M
-1cm-1; menaquinol, ε330 = 3100 M
-1cm-1, 18’-
methylene CoQ8, ε280 = 3850 M
-1cm-1 (from this work)).
Octanol-water Partition Coefficients of Exogenous Quinols
An amount of the solid quinol was dissolved in octanol to give a maximal
absorbance of 0.7 to 0.9.  A 25-mL aliqout of the octanol solution of the quinol was
shaken with 25 mL of water (acidified with 3mN HCl), in a separatory funnel for 15
minutes.  The octanol layer was drained into a beaker containing a few grams of Na2SO4
to remove water.  The partition coefficient was defined as the proportion of the quinol
that remained in octanol after equilibrating with water.  This was determined from the
UV absorbance of the octanol layer before and after shaking with water.
pMMO Detergent Solubilization
Detergents were prepared as stock solutions containing 10 or 20% detergent (w/v)
in 10mM PIPES, pH 7.0.  The detergent stock solution was added with stirring (or
vortexing) to membrane suspensions containing 5 – 45 mg/mL of total protein.  This
detergent/membrane suspension was vortexed at room temperature or at 3°C for 15 to 45
minutes (variation of the time and temperature had no significant effect on pMMO
activity of the solubilized fraction).  The suspension was then centrifuged at 106,000xg
for 60 to 90 minutes to separate the detergent-solubilized proteins from the insoluble
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pellet.  The soluble fraction was used without further manipulations.  For assays of the
insoluble fraction, the pellet was resuspended in the original volume of 10mM PIPES
buffer, pH 7.0 using a Dounce homogenizer.  Lauryl maltoside was obtained from
Calbiochem or Anatrace and used without further purification.  Other detergents were
obtained from Boehringer-Mannheim.
Acetylene Labeling of pMMO
In a septum-sealed vial, ∼500µL of detergent-solubilized membrane sample was
incubated with 75µL of [14C]-acetylene (60mCi/mmol; New England Nuclear) in air, for
at least 30 minutes (previous time course experiments indicated that all of the available
acetylene binding sites were occupied in <30 minutes).  Samples were evacuated and
flushed with 1mL of unlabeled acetylene to remove non-specifically bound radioactivity,
incubated for 5 minutes at room temperature, evacuated, and flushed with acetylene
again.  Radioactivity was measured by scintillation counting of 150µL of the sample in
3mL of Dimiscint for 5 minutes on a Beckman LS 5000TD scintillation counter.
Aliquots of the same [14C]-treated samples were electrophoresed as described below.
Radiolabeled bands were detected using a Molecular Dynamics phosphorimager, with
ImageQuant software.
Gel Electrophoresis
SDS-PAGE was performed according to the method of Laemmli (3).
Radiolabeled samples were diluted fourfold with a 1:1 mixture of sample dye (50%
glycerol; 0.01% bromophenol blue) and sample buffer (0.25M Tris, pH 6.8; 8% SDS).
An appropriate volume (∼50µL) of the prepared samples was loaded onto the lanes of a
15% discontinuous polyacrylamide gel with a 4.5% stacking gel.  Molecular weight
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markers (Sigma) were loaded in adjacent lanes to calibrate the molecular weight of the
proteins.  Samples were electrophoresed at a constant current of 30mA until complete
(∼4-5 hours).  The gels were fixed (50% methanol; 10% glacial acetic acid) for 30
minutes, stained for ∼2 hours with 0.16% Coomassie blue G-250 (Inprotech).  And
destained overnight (10% methanol; 12% glacial acetic acid).
Oxygen Uptake Studies
The rate of oxygen uptake was measured in both membrane fractions and whole
cell suspensions, using a YSI polarographic oxygen electrode equipped with a constant
temperature circulating water bath.  All experiments were performed at 42°C.  The
sample chamber contained 3.0mL of the sample suspension in 10mM PIPES (pH 7.0).
After an initial incubation of the sample buffer (typically 10 minutes), the probe was
lowered into the chamber and the probe/membrane allowed to come to temperature.
Excessive noise in the baseline was eliminated by overnight incubation of the probe in a
dilute sample of membrane or whole cell suspension to reduce static electricity.  After
attaining a relatively stable baseline, the appropriate sample was delivered into the
sample chamber using a Hamilton syringe.  After the oxygen uptake curve reached a
linear stage, substrate was added to increase respiration above basal levels.  If inhibition
studies were performed, the appropriate inhibitor was added after the substrate-stimulated
rate was linear.  The following inhibitors were used: piericidin A (a gift from Dr.
Thorsten Friedrich), amytal (Eli Lilly Company), rhein (Sigma), HQNO (Sigma),
caffeine (Sigma), myxothiazole (Sigma), antimycin A (Sigma), SHAM;
Salicylhydroxamic acid (Sigma), cyanide (Fisher Scientific), octyl gallate (Sigma).
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Isolation, Purification and Characterization of Endogenous Quinones
A single culture of pMMO-expressing Methylococcus capsulatus was used for
this study.  The cells were grown, harvested, and lysed as mentioned above.  The pelleted
membrane material was lyophilized for 48 hours then placed into a 1-L beaker to which
500mL of n-pentane (Fisher Scientific) was added.  The suspension was stirred for 5
hours to extract the hydrophobic quinones.  The suspension was gravity filtered through
magnesium sulfate (Fischer Scientific) in analytical grade Whatman filter paper placed in
a glass funnel.  The filtrate (approximately 350mL) was filtered once again through
analytical grade filter paper to remove any debris which had escaped the first pass.  The
canary yellow extract was then examined via UV-visible spectrophotometry from 200 to
400nm utilizing an SLM Aminco DW 2000 spectrophotometer for the broad 280nm
absorbance characteristic of quinones.  The extract was dried to a viscous oil and
dissolved in HPLC grade methanol (Fisher Scientific) to a volume of approximately 120-
mL.  BHT was added to inhibit oxidation.  The extract was chromatographed using a
Waters Millennium HPLC system interfaced with a Waters 996 Photodiode array
detector.  The quinones were eluted from a Waters reversed-phase C18 column (250 x 4.6
mm) under an isocratic system (1.0ml/min) with pure methanol (HPLC grade) as the
mobile phase.  No pre-column or in-line filters were used.  The quinones were detected at
a wavelength of 280 nm.  To aid in identification, one of the purified analytes was mixed
with a solution of quinone standards (Q6, Q7, Q9, and Q10; Sigma).  This mixture was
chromatographed as above, with a flow rate of 0.5 mL/min.  All integration and data
manipulation was performed with the Waters Millennium software.
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GC/MS were recorded using a Finnigan Model 4500 mass spectrometer interfaced
with a Varian Model 3400 gas chromatograph containing a DB-5 column using a direct
insertion probe.  Ionizing voltage ranged from 18eV to 70eV with a temperature range of
50 to 300°C at 60 degrees/minute.  Data manipulation was performed using an Incos data
system.  1H and 13C NMR spectra were recorded on a Varian 300MHz FT-NMR.
Nuclear magnetic resonance samples were dissolved in deuterated chloroform.
Spectroscopic Kinetic Studies
The reduction of cytochrome c was followed as a function of time at a wavelength
of 555 nm.  This was performed on an SLM Aminco DW-2000 UV-visible
spectrophotometer equipped with a stirring apparatus.  Samples were maintained at 42°C
with the aid of a constant temperature bath and water circulation attachment surrounding
the sample cuvette(s).  Reduction experiments were performed on pMMO-expressing M.
capsulatus membrane preparations (suspended in 10mM PIPES, pH 7.0) with methanol
(Fisher Scientific) as the source of reducing equivalents.  To inhibit flow of reducing
equivalents, octyl gallate (Sigma) and potassium cyanide (Fisher Scientific) were utilized,
dissolved in methanol (or DMSO) and water, respectively.  For changes in signal
amplitude, exogenous cytochrome c (horse heart, Sigma) was added to the sample cuvette
from a stock solution of the protein dissolved in 10mM PIPES, pH, 7.
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ABSTRACT
Quinols can provide reducing equivalents for the membrane-bound methane
monooxygenase (pMMO), substituting for NADH in whole cells and membranes.
Furthermore, quinols are effective reductants for the detergent-solubilized enzyme,
whereas NADH is ineffective.  The decyl analog of plastoquinol and duroquinol (2,3,5,6-
tetramethylbenzoquinol) provide the greatest methane monooxygenase activity in whole
cells and membrane suspensions, as well as detergent-solubilized samples.  Lauryl
maltoside is by far the best detergent for solubilization of catalytically active methane
monooxygenase.  Optimal pMMO activity in the detergent-solubilized fraction is
obtained with a ratio of ~1.7milligram of detergent per milligram of membrane protein,
independent of protein concentration.  The detergent-solubilized pMMO retains its
sensitivity to inhibition by cyanide, acetylene, and EDTA.  It is also stimulated by
exogenous copper, as in isolated membrane fractions.  Reaction of the detergent-
solubilized enzyme with [14C] acetylene results in labeling of the 26-kDa peptide,
analogous to the behavior observed for isolated for isolated membrane suspensions.  The
selectivity of pMMO for duroquinol and decyl-plastoquinol, relative to other structurally
similar quinols suggests that the enzyme obtains reducing equivalents directly from a
quinol (probably plastoquinol) in vivo.
35
INTRODUCTION
Methane monooxygenase (MMO) is the O2-dependent enzyme that initiates
methane oxidation in methanotrophic bacteria (3).  The enzyme also requires reducing
equivalents, presumably to activate O2.  As is typical of mixed-function oxygenases (15),
the oxygen molecule is split during catalysis, with one oxygen atom reduced to water,
and the other oxygen atom incorporated into methane, producing methanol (1).  Methanol
is subsequently oxidized to formaldehyde by methanol dehydrogenase, generating
reduced cytochrome c (11).  Formaldehyde can be assimilated to provide carbon, or
further oxidized to carbon dioxide, thereby providing energy for the organism (2).
MMO is critical to the global carbon cycle, initiating the major route for methane
produced by anaerobic fermentation to re-enter the biosphere (12).  Knowledge of the
enzymatic mechanism of MMO may aid in the design of catalysts for the large-scale
oxidation of methane.  Such catalysts are crucial to the more effective use of methane as
a fuel and industrial feedstock (17).  In addition, MMO is one of the few enzymes able to
oxidize small, unactivated alkanes and halogenated hydrocarbon solvents (9), such as
trichloroethylene (others include ammonia monooxygenase (4), propane monooxygenase
(32), and toluene dioxygenase (31)).  Hence, methanotrophic bacteria (and MMO) are the
focus of many investigations utilizing bioremediation to remove such solvents from
groundwater (23).
Two distinct forms of methane monooxygenase are known.  The soluble form
(sMMO) is a cytosolic, multi-component enzyme that obtains reducing equivalents
directly from NADH.  It has been purified to homogeneity, and a high-resolution crystal
structure has recently been published (21).  The hydroxylase component of sMMO
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contains two dinuclear-iron active sites.  The membrane bound form of MMO (referred to
as pMMO, since it is localized in the particulate fraction) has not been well characterized.
Previous reports of the purification of pMMO (29, 1) are not reproducible (3), hence little
is known regarding its structure and mechanism.  In contrast with sMMO, copper is
required for pMMO activity (18, 16).  This copper appears to be loosely bound, as
pMMO is inhibited by metal chelators such as EDTA, and dithiocarbamates, which have
no effect on sMMO (22, 28).  The two forms of MMO also differ in substrate specificity:
sMMO can oxidize large aliphatic and aromatic compounds, whereas pMMO cannot
oxidize hydrocarbons larger than butane (3, 5).  Although several species of
methanotroph are able to express both pMMO and sMMO, they are not expressed
concurrently, and are the products of separate genes (26, 27).  The ammonia
monooxygenase (AMO) found in ammonia-oxidizing bacteria is similar to pMMO in all
of the aspects described above (10).  AMO has not yet been purified and also remains
poorly characterized.
Progress in purification and characterization of pMMO has been slowed by the
lability of the enzyme in vitro, and the lack of methods for preparing active, detergent-
solubilized pMMO.  The problem of pMMO instability has recently been resolved: it
results primarily from the disociation of weakly-bound copper (16).  The enzyme is
stabilized in vitro by excess copper.  Solubilization of active pMMO remains the major
obstacle to purification of this enzyme.  Although Dalton and coworkers reported
solubilization of pMMO with lauryl-maltoside, activation of the enzyme required
reconstitution with phospholipids, and the reconstituted preparations were inactivated by
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fractionation (25).  Solubilization with other detergents resulted in complete inactivation
that could not be reversed by reconstitution with phospholipids (25).
The results of Smith and Dalton (25) could arise from detergent-induced
disruption of an electron-transport chain from NADH to pMMO.  In contrast, a reductant
that directly reduces pMMO should be able to support activity after detergent
solubilization.  To test this theory, we have examined a wide range of reducing agents for
their ability to donate electrons to pMMO.  Our results suggest that quinols are capable of
directly reducing membrane-bound and detergent-solubilized pMMO.  The enzyme is
selective for specific quinols, suggesting that the reductant in vivo is also a quinol.
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RESULTS
Reduction of Membrane-bound MMO by Quinols
As is true of all monooxygenase enzymes, pMMO requires reducing equivalents
for activity.  In this report we show that certain quinols can replace NADH as the source
of reducing equivalents for pMMO from M. capsulatus.  The activity of pMMO in whole
cells and membranes is significantly greater with decyl-plastoquinol and duroquinol
despite their structural similarity to the less effective quinols (Fig. 1).  Duroquinol and
decyl-plastoquinol were not as effective as NADH however, perhaps due to the low
solubility of the quinols in aqueous solution.  The pMMO activity of the membrane
suspensions was proportional to duroquinol concentration, and was saturated at ~2mM
duroquinol (data not shown).  Other reductants that are effective with many
monooxygenases and oxidases were also examined for their ability to reduce pMMO,
including dithionite, ascorbate, methyl viologen, benzyl viologen, and ascorbate/TMPD.
In no case was pMMO activity observed in membranes treated with these reductants.
Detergent-solubilization of pMMO
Addition of lauryl maltoside to membrane suspensions enhanced the pMMO
activity with all of these quinol reductants, especially decyl-plastoquinol (data not
shown).  No pMMO activity with NADH as the reductant was observed after
solubilization.  This observation appears to result from disruption of electron transfer
from NADH to pMMO, since the solubilized enzyme remained active with duroquinol as
the reductant, as demonstrated in Fig. 2.  In this experiment, membranes were treated
with increasing concentrations of lauryl-maltoside, and the soluble and pellet fractions
were assayed separately for pMMO activity, using either NADH or duroquinol as the
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Figure 1
Structures of the quinol reductants used to assay pMMO activity.
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Figure 2
Increased detergent concentration shifts pMMO activity from the membrane to the
soluble fraction.  The activity of pMMO in the detergent-solubilized fraction (A) and
insoluble fraction (B), are shown as a function of lauryl-maltoside concentration with
duroquinol (•) or NADH (♦) as reductant.
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electron donor.  With duroquinol, the pMMO activity of the soluble fraction was
proportional to detergent concentration (Fig. 2A).  In contrast, NADH-dependent pMMO
activity was observed exclusively in the pellet, and was inversely proportional to
detergent concentration (Fig. 2B).  Duroquinol-dependent pMMO activity in the pellet
was also inversely proportional to detergent at concentrations greater than 1.5% (Fig.
2B).  The stimulatory effect of lauryl-maltoside is responsible for the initial increase in
the duroquinol-dependent activity of the pellet (Fig. 2B).  No pMMO activity was
observed in the detergent-solubilized fraction in the presence of dithionite, ascorbate, or
methyl viologen.  Thus, pMMO remained active after solubilization, but only with
specific quinol reductants.
Fig. 3 shows that a detergent-to-protein weight ratio of ~1.7 was optimal for
solubilizing active pMMO, and activity decreased markedly when the detergent
concentration increased further (Fig. 3).  The efficiency of solubilization was independent
of protein concentration: maximum activity was observed at the same detergent-to-
protein ratio for membranes suspensions containing 7mg mL-1 and 20 mg mL-1 total
protein (Fig 3).  The amount of protein in the soluble fraction increased similarly, also
reaching a maximum at ~75% of the total membrane protein with a detergent-to-protein
ratio of ~1.7 (Fig. 3).  For reasons that remain unclear, solubilization of highly active
pMMO from M. capsulatus membranes was possible only with lauryl-maltoside.  No
pMMO activity was observed with duroquinol or NADH, in either the supernatant or
pellet, after solubilization with Triton X-100, Tween-20, zwittergent 3-12, nonidet P40,
or synperonic.  Although some pMMO activity was observed after solubilization with
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Figure 3
Solubilization of pMMO from the membranes as a function of lauryl-maltoside-to-protein
weight ratio.  Membranes were solubilized at a protein concentration of 7mg mL-1 (ο), or
20 mg mL-1 (•).  The specific activity of pMMO in the soluble fraction was determined in
the presence of 15mM duroquinol and is reported relative to the specific activity of the
membrane fraction assayed with duroquinol (0.7 nmol min-1 mL-1).  The percentage of
total protein solubilized is shown for the 20 mg mL-1 sample (♦).  Similar results were
obtained at 7 mg mL-1.
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diheptanoyl-phosphatidylcholine, it was <10% of the activity observed with lauryl-
maltoside (data not shown).
The relative activities of the quinols with detergent-solubilized pMMO is similar
to that observed with whole cells and membranes (Table I), indicating the enzymatic
mechanism is unaffected by solubilization.  Detergent-solubilized pMMO exhibited
stimulation by copper and inhibition by cyanide, EDTA, and acetylene (Table II), as does
the membrane-bound enzyme (3, 16), providing additional evidence that the catalytic
core is not altered by solubilization.  Finally, suicide inhibition of pMMO by acetylene
was also unaffected by solubilization.  Treatment of the detergent-soluble fraction with
[C14] acetylene, O2, and duroquinol results in irreversible inhibition of pMMO (Table II),
and irreversible binding of the radiolabel (Fig. 4).  Just as with membrane-bound pMMO,
the irreversible binding of acetylene to the detergent-solubilized enzyme requires a
reductant (duroquinol in this case), and is prevented by the pMMO inhibitor EDTA, and
by protein denaturation (Fig. 4).  Electrophoretic analysis of the solubilized fraction after
exposure to [C14] acetylene and duroquinol shows the radiolabel bound primarily to a 26
kDa protein, a significantly weaker radiolabeled band is observed with an apparent
molecular weight of ~50 kDa (Fig. 4, inset).  This band may result from aggregation of
the 26 kDa protein, as previously reported for pMMO from M. capsulatus (9).  The low
molecular weight radiolabeled band in Figure 4 ran near the dye front and may be due to
degradation of the 26 kDa protein or reaction of oxidized acetylene with buffer,
detergent, or phospholipid.
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Table 1  Comparison of pMMO activity with various substituted para-benzoquinols.
pMMO Specific Activity (nmol min-1mg-1)
     Soluble         Redox
   Reductant          Whole Cells     Membranes    Fractionb      Potentialc   Hydrophobicityd
NADH    24.2e                 6.2             <0.1           -340 mV            n.d.f
Decyl-plastoquinol       4.44                0.38             2.70             30mV        97.9±0.008
Duroquinol    2.90                1.56             1.46             50mV        96.7±0.005
Decyl-Ubiquinol           0.41                0.18             0.36              40mV      94.6±0.005
Coenzyme Q0                1.22                0.08             0.18                                90.4±0.02
Menaquinol                    0.06              <0.05            0.06               0mV         96.8±0.008
2,3-Dimethyl Quinol    <0.05                 n.d.          <0.05             210mV       96.3±0.002
Trimethyl Quinol           0.12                  n.d.            0.07             115mV       96.4±0.006
aReductants were present at concentrations of 5mM for whole cells and membranes,
10mM for the soluble fraction.  Structures of the quinones are shown in Figure 1.
bMembranes were solubilized with a detergent:protein weight ratio of 1.7, with lauryl
maltoside.  cE0’ values from reference 8.  dThe octanol-water partition coefficients for the
quinols determined at room temperature.  Values represent the average of 6-10 separate
determinations.  eActivity assayed with 5mM Formate. fnd, not determined.
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Table 2  Effect of Inhibitors and Cu(II) on Solubilized pMMOa.
         __   Addition______                    pMMO Activity (% of Control)
                      None                                                                    100
                      EDTA (1.5mM)                                                   18.1
                      Cyanide (2mM)                                                     <2
                      Acetylene (10% by vol.)                                        4.3
                      Cu2+ (400µM)                                                        348
aThe pMMO was solubilized with a detergent /protein weight ratio of 1.7, and pMMO
activity was measured in the presence of 7.5mM duroquinol.
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Figure 4
Radiolabeling of detergent solubilized pMMO by [14C] acetylene requires quinol and
catalytically-competent pMMO. The bar graph shows the relative radioactivity of the
soluble fraction after incubation with [14C] acetylene with and without duroquinol, with
duroquinol plus 2mM EDTA, and with duroquinol after briefly boiling the sample.  The
radioactivity of the control fraction was 2.0 x 106 CPM.  The inset is an auto-radiogram
showing the 26kDa peptide that is predominantly labeled during incubation of the soluble
fraction with duroquinol and [14C] acetylene.  The high molecular weight band has a
mass of ~50 kDa, and the low molecular weight band ran with the dye front.
47
DISCUSSION
Reduction of pMMO by Quinols in vitro
The membrane-bound form of MMO remains poorly characterized, primarily due
to the lack of methods for purification of the enzyme.  Purification procedures cannot be
developed however, unless the enzyme can be solubilized from the membrane in an
active form.  In this communication we have shown that pMMO can be solubilized with
lauryl maltoside, and it retained high activity if duroquinol or decyl-plastoquinol are
present as the reductant (Table I, Figure 2).  Approximately 25% of the total quinol-
dependent activity of whole cells is retained in the detergent-soluble fraction, with a
quinol-dependent specific activity comparable to that of whole cells and membranes
(Table I), indicating that the catalytic properties of the enzyme are unaffected by
solubilization.  Moreover, detergent-solubilized and membrane-bound pMMO are
completely analogous with respect to stimulation by copper; inhibition by EDTA,
cyanide, and acetylene (Table II); and irreversible binding of [C14] acetylene (Fig 4).  The
only significant change that occurs upon solubilization is that pMMO can no longer use
NADH as electron donor, whereas the ability to utilize quinols is unaffected (Table I).
The relative ability of these quinols to support pMMO activity (Table I), provides
insight into the mechanism and physiological relevance of this redox reaction.  One
mechanism for exogenous quinols to serve as electron donors to membrane-bound
enzymes is by reducing the endogenous quinone pool.  The rate of this type of
mechanism depends primarily on thermodynamic driving force (20), hence it should be
inversely related to the redox potential of the exogenous quinol.  This mechanism was
proposed for the reduction of AMO by quinols in whole cells of Nitrosomonas europea,
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since activity with methyl-substituted quinols was inversely related to their redox
potentials (24).  In the case of pMMO we observe no such correlation: duroquinol and
decyl-plastoquinol have potentials similar to the ubiquinol and menaquinol analogs but
are significantly more effective at reducing pMMO (Table I).  Furthermore, the
detergent-solubilized fraction should be depleted of endogenous quinols, yet pMMO
activity with duroquinol and decyl-plastoquinol is not altered (Table I).  Thus, it seems
likely that these exogenous quinols reduce pMMO by binding directly to the catalytic
core of the enzyme, or to a reductase that remains bound to pMMO after solubilization.
The ability of these exogenous quinols to directly reduce pMMO in vitro may
result from their similarity to the natural reductant for pMMO in vivo (i.e., an endogenous
quinol).  Alternatively, reduction of pMMO by exogenous quinols in vitro may be
adventitious, with no physiological relevance to the natural reductant.  In this regard, we
note that the most hydrophobic quinols are al so the most effective reductants for pMMO
(Table I).  It is conceivable that the greater hydrophobicity of duroquinol and decyl-
plastoquinol enhances their access to the active site cofactors.  However, the difference in
hydrophobicity of these quinols is small, whereas the difference in pMMO activity is
great (Table I).  Furthermore, the selectivity of pMMO for specific quinols is not
consistent with this type of non-specific reduction.  For example, duroquinol is much
more effective than menaquinol despite similar size, redox potential, and hydrophobicity
(Table I).  In addition, the active site of pMMO is not readily accessible: hydrocarbons
larger than butane are not oxidizable by pMMO and aromatic reductants, such as methyl-
viologen, benzyl-viologen, and TMPD are unable to reduce pMMO.  The possibility that
the exogenous quinols non-specifically reduce a redox cofactor remote from the pMMO
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active site also seems inconsistent with the much greater activity of duroquinol and
decyl-plastoquinol, relative to the other quinols.  Although the dimethyl- and trimethyl-
quinols are structurally similar duroquinol and decyl-plastoquinol, they are not effective
reductants for pMMO (Table I), perhaps a result of the relatively high redox potentials of
the former two quinols.  Thus, it appears the greater activity of duroquinol and decyl-
plastoquinol results from their similarity in structure and redox potential to quinols that
reduce pMMO in vivo.
In whole cells, membranes, and detergent-solubilized fractions the pMMO
activity is much greater with duroquinol and decyl-plastoquinol as electron donor,
relative to decyl-ubiquinol (Table I).  This is also the case for enzymes that are
specifically reduced by plastoquinols (13), whereas the opposite is true for enzymes that
are specific for ubiquinols (14).  Therefore, if the natural reductant for pMMO is a quinol,
it is probably plastoquinol, rather than ubiquinol.  Several investigations of the quinone
content of methanotrophs (30, 6), have demonstrated that M. capsulatus and other
methanotrophs contain significant amounts of ubiquinone, and no menaquinone.
Unfortunately, no mention is made of plastoquinone in these reports.  Thus, which
plastoquinones are present in M. capsulatus, if any, remains a subject for future study.
Reduction of pMMO by Quinols in vivo
As we show in Table I and Fig. 2, NADH can provide reducing equivalents for
pMMO in whole cells and membranes, but not after detergent solubilization.  In contrast,
duroquinol and decyl-plastoquinol are at least as effective before solubilization as after
(Table I).  This, together with the specificity for these particular quinols, suggests that the
quinone pool is required for reduction of pMMO by NADH.  Thus, we propose the
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existence of an electron-transport chain for the reduction of pMMO in vivo, as illustrated
in Scheme 1.
   Formate
NADH Quinone pMMO
Formaldehyde    Pool
Scheme 1:  Proposed electron-transport chain for reduction of pMMO in M. capsulatus.
Methanotrophs are known to generate NADH from the oxidation of formaldehyde
and formate (3).  In this putative electron-transport chain, NADH is utilized to reduce the
quinone pool, which subsequently reduces pMMO.  The NADH dehydrogenase inhibitor
amytal is reported to inhibit NADH-dependent pMMO activity in membranes from
Methylosinus trichosporium (22), consistent with this type of electron-transport chain.
The pMMO in membranes from these latter bacteria can obtain reducing equivalents
from succinate (7), suggesting that a succinate dehydrogenase similar to complex II of
mitochondria catalyzes reduction of the quinone pool by succinate.  M. capsulatus
apparently lacks this succinate dehydrogenase, since succinate supports neither pMMO
activity or oxygen uptake in membranes from these bacteria (data not shown).  Thus,
transfer of reducing equivalents from low potential electron donors (NADH, formate,
succinate, etc.) to pMMO appears to be mediated by quinones in both of these
methanotrophs.  As discussed above, our results are consistent with direct reduction of
pMMO by exogenous quinols, as a result of their similarity to a natural plastoquinol
reductant.  However, we cannot rule out the requirement for other redox proteins to
catalyze reduction of pMMO by quinols in vivo.  If such a quinol/pMMO reductase exists
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it appears to be tightly bound to pMMO, remaining associated after detergent
solubilization.
The requirement for quinols to mediate reduction of pMMO by NADH could
explain why previous attempts to solubilize the enzyme were unsuccessful.  Detergent
solubilization apparently inactivates the enzyme that catalyzes reduction of quinones by
NADH, or separates this enzyme from pMMO, so reduction by NADH is no longer
possible.  The results of Smith and Dalton indicate that the electron transfer chain from
NADH to pMMO can be reassembled in phospholipid vesicles, but it is not stable enough
to survive fractionation (25).  The use of quinols to assay pMMO activity during
purification should eliminate the need to co-purify the additional enzymes needed for
reduction by NADH, and facilitate purification of the catalytic core of pMMO.
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CHAPTER FOUR
Isolation, Purification, and Characterization of Endogenous Quinones
and Their Use in Support of pMMO Activity in vitro
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INTRODUCTION
The particulate form of methane monooxygenase (pMMO) initiates the utilization
of methane in methanotrophs (3).  It performs this reaction by accepting reducing
equivalents from an, as yet, unknown source.  It had previously been believed that the
two reducing equivalents came directly from NADH.  However, solubilization of the
enzyme (with lauryl maltoside) resulted in complete loss of activity when using NADH
as the reductant.  Apparently, either an intermediary component of the chain between
NADH and pMMO was lost during solubilization or the enzyme itself underwent a
detergent-driven, irreversible conformational change.
Our initial model of the respiratory chain of Methylococcus capsulatus depicts
several proteins of interest, transferring reducing equivalents from the oxidation of
methane ultimately to molecular oxygen, reducing it to water.  However, experimental
characterization of the chain has largely been limited to the interaction of pMMO with
exogenous quinols (previous chapter) (18).  Recently, Cook and Shiemke purified a
NADH-dependent type II dehydrogenase capable of reducing exogenous quinols in vitro.
Prior to this, individual studies of methanol dehydrogenase (9) and a caa3-type oxidase
(7) summarized what was known about the respiratory enzymes in M. capsulatus.  The
study of endogenous respiratory lipids (i.e., quinones) has been ignored, to date, with the
exception of a quinone purification from M. capsulatus by Collins, et al. (4).
Subsequently, Nguyen, et al. reported the isolation of a crude quinone extract from M.
capsulatus, but no details of the purification or characterization of their extract were
reported (15).
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Several types of quinones are known to be important intermediates in the transfer
of reducing equivalents through the respiratory chains of living systems (11,16).
Typically, the ubiquinones are found within prokaryotic and eukaryotic cells, while
plastoquinones and menaquinones are spread largely among plants and bacteria.
Rhodoquinone, on the other hand, has so far only been found in a subset of
photosynthetic bacteria. (14).  Ubiquinone-10 (CoQ10) is the mobile electron carrier
found in eukaryotic horse heart mitochondria (20) and CoQ9 is found in the mitochondria
of rats (13).  Plastoquinone is found in spinach chloroplasts (12) and menaquinone is the
agent located in a wide variety of bacteria (13).
This chapter reports the isolation, purification, and characterization of three
endogenous quinones, two of which have not previously been reported.  The crude
extract as well as the purified form of one of the quinones were assessed for their ability
to support pMMO activity in vitro.  This is the first report to show endogenous quinone-
dependence of pMMO activity.
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RESULTS
Isolation, Purification, and Characterization of the Endogenous Quinones from the
Membrane Fraction of pMMO-expressing Methylococcus capsulatus
As seen in Figure 1, reversed phase chromotography of the n-pentane extract
yielded several prominent, well-resolved peaks.  The large peak at approximately 3.8
minutes is due to a preservative (BHT) added to prevent oxidation of the aliphatic
isoprenoid tail.  The remaining six prominent peaks as well as a pooled sample of the
regions between the peaks were analyzed by UV-visible spectroscopy as well as GC/MS
to ascertain the presence and/or level of quinone compounds exhibited.
Analysis of peak #1 (9.1 minutes), peak #2 (12.8 minutes), and peak #3 (14.3
minutes) by UV-visible or GC/MS showed no evidence of the presence of quinones (data
not shown).  The instrumental GC/MS library search resulted in an array of possibilities
for these first three peaks, some of which were lipids, but none of which were quinones.
Similarly, the pooled regions between the prominent peaks also suggested no quinones
were present at these points.
Conversely, the peaks at 19.0 minutes, 26.0 minutes, and 28.0 minutes (from this
point forward referred to as peak #4, peak #5, and peak #6, respectively) exhibited
entirely different results.  Peak #4, the major component of the extract, was the focal
point of this work.  An aliquot of this peak was chromatographed via silica TLC yielding
a single spot which co-chromatographed with standard coenzyme Q10.  However, no
indication that menaquinone (vitamin K2) was present when comparing to such standard.
The purified fraction of peak #4 was then mixed with an array of ubiquinone
standards (CoQ6, CoQ7, CoQ9, and CoQ10) in methanol, and the resultant chromatogram
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Figure 1.  Reversed-phase chromatograph of crude n-pentane quinone extract from
Methylococcus capsulatus (Bath).  Peaks 1-3 are non-quinone organics, peak #4 is 18’-
methylene CoQ8, peak #5 is CoQ9, and peak #6 is 18’-methylene CoQ9.
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is depicted in Figure 2 (A).  Peak #4 eluted between CoQ7 and CoQ9.  The log10 of the
retention time for each standard was then plotted vs. number of isoprene units in each
respective tail (Figure 3).  Interpolation of the graph of retention time vs. isoprene units
yielded an experimental value of 8.1 isoprenes in the tail of peak #4.  Additionally, the
UV-visible spectrum of peak #4 exhibited the same maxima and general envelope shape
as those from the standards (Figure 2, B).
Following HPLC purification, peaks #4, 5, and 6 were analyzed via gas
chromotography/ mass spectrometry (Figures 4-6).  All three analytes exhibit fragment
ions at m/e = 235 (base peak) and m/e = 197 indicative of ions from the ubiquinone class
of compounds as illustrated in Figure 7 (4).  There is also a prominent M + 2 ion in each
of the spectra indicative of the dismutations resulting in the quinol form.  The rhythmic
pattern between M – 15 and m/e = 235 were not apparent for the loss of successive
isoprene units.  None of the spectra recorded showed evidence of plastoquinone, which
would exhibit prominent signals at m/e = 151 and m/e = 189, suggesting that
Methylococcus capsulatus does not produce this class of quinones.
The parent ion in peak # 4 was identical to that reported previously by Collins &
Green in 1985, who concluded that it was 18’-methylene CoQ8.  However, the parent
ions observed in peaks #5 and #6 differed from anything previously reported for
Methylococcus capsulatus.  The parent ion observed for peak # 5 was consistent with that
of ubiquinone-9 (CoQ9) (as was the rest of the mass spectrum) within experimental error.
The published parent ion is reported at m/e = 794 while that observed in this data
occurred at m/e = 795.  Peak # 6 resulted in a parent ion of 808, approximately 14 mass
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Figure 2.  A) Reversed-phase chromatograph of purified peak #4 co-chromatographed
with quinone standards.  The flow rate was reduced two-fold from that used in Figure 1.
B) UV spectra of the standards and peak#4 (18’-methylene CoQ8) were recorded at the
apex of the respective peaks (bottom) to note similarity.  CoQ6 (Blue), CoQ7 (Red), 18’-
methylene CoQ8 (Yellow), CoQ9 (Green), CoQ10 (Purple).
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Figure 3.  Log10 Retention Time vs. Tail Length (# Isoprene Units).  Data values for the
four quinone standards are shown with a regression line calculated.  Extrapolation of the
retention time for peak # 4 yields a result of 8.1 isoprenes in the tail of peak #4.
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Figure 4.  GC mass spectrum of 18’-methylene CoQ8.  Molecular ion occurs at m/e =
740.2, and base peak at m/e = 235.0.  Also, note the molecular ion at m/e = 197.0.
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Figure 5.  GC mass spectrum of CoQ9.  Molecular ion occurs at m/e = 795.1 and base
peak at 235.0.  Also, note the molecular ion at m/e = 197.1.
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Figure 6.  GC mass spectrum of 18’-methylene CoQ9.  Molecular ion occurs at m/e =
808.6, and base peak at m/e = 235.3.  Also, note the molecular ion at 197.3.
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Figure 7.  Fragmentation scheme for the ubiquinone class of compounds.  General
molecular structure is given at the top as well as the structures of the base peak (m/e =
235) and other prominent ions occurring at m/e = 197.0.
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units higher than that for peak # 5.  It is likely that this analyte would be 18’-methylene
CoQ9.
The 1H and 13C NMR spectra as well as COSY spectrum of peak #4 are illustrated
in Figures 8, 9 and 10.  These spectra confirm the identity of this sample as 18’-
methylene CoQ8.  Of particular note were signals in the 
13C spectrum.  Signals at
154.555ppm and 107.468ppm were indicative of the vinylic (C=CH2) group.  Other
signals at 25.7278ppm, 35.6146ppm, 107.468ppm, 20.1465ppm, 38.4198ppm, and
32.4187ppm confirmed the position of the vinyl group on the 5th isoprene from the ring.
Other confirmatory structure information was gained from the 1H NMR (such as the
presence of the methoxy protons) and COSY spectra (presence and/or positions of
aliphatic protons on the isoprene chain).  The proposed structure for the endogenous 18’-
methylene CoQ8 is reproduced in Figure 11 with the carbon-13 shift assignments (ppm)
noted for reference.
Enzymatic Activity Assays
Once the structure of the major quinone component was known, we next
investigated what effect, if any, the endogenous quinone has on pMMO activity.  Three
different environments were analyzed with regards to pMMO activity: (I) whole cells, (ii)
membranes, and (iii) solubilized membrane fraction.
As Table 1 illustrates, the highest specific activity was observed in whole cells,
with formate as reductant.  After lysing the cells, specific activity for pMMO drops
significantly in the membrane fraction with NADH as reductant, as previously reported
(Chapter 3).  The specific activity drops still further (to ~0) after solubilization, when
NADH is the reductant.  We hypothesized that the quinone pool of M. capsulatus may be
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Figure 8.  13C NMR spectrum of 18’-methylene CoQ8 (Peak #4).  Solvent was CDCl3
and chemical shifts are expressed as ppm
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Figure 9.  1H NMR spectrum of 18’-methylene CoQ8 (Peak #4). Solvent was CDCl3 and
chemical shifts are expressed in ppm.  Integration results are depicted below the spectrum
in red.
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Figure 10.  1H COSY spectrum of 18’-methylene CoQ8 (Peak #4).  Solvent was CDCl3
and chemical shifts are expressed in ppm.  Total acquisition time was 7 hours, 6.9
minutes.
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Figure 11.  Proposed chemical structure of Peak #4 (18’-methylene CoQ8) with
theoretical chemical shifts.
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Table 1.  Stimulatory Effects of Quinones on pMMO
Sample Reductant Specific Activity1
Whole Cells Formate (5mM) 38.3 ± 2.4
Whole Cells Decyl-plastoquinol (5mM) 6.1 ± 0.4
Whole Cells Duroquinol (5mM) 4.1 ± 0.3
Whole Cells 18’-MQ8H2 (250uM) 0.4 ±  0.1
Whole Cells 18’-MQ8H2 (500uM) 0.3 ±  0.07
Whole Cells 18’-MQ8H2 (1mM) ~ 0
Membranes NADH (5mM) 6.1 ± 0.6
Membranes Decyl-plastoquinol (5mM) 0.6 ± 0.1
Membranes Duroquinol (5mM) 2.1 ± 0.2
Membranes 18’-MQ8H2 (250uM) ~ 0
Membranes 18’-MQ8H2 (500uM) 0.2 ± 0.05
Membranes 18’-MQ8H2 (1mM) 0.4 ± 0.03
Soluble Fraction NADH (10mM) ~ 0
Soluble Fraction Decyl-plastoquinol (10mM) 4.9 ± 0.3
Soluble Fraction Duroquinol (10mM) 1.1 ± 0.05
Soluble Fraction 18’-MQ8 (250uM)a 0.8 ± 0.04
Soluble Fraction 18’-MQ8 (500uM)a 1.9 ± 0.08
Soluble Fraction 18’-MQ8 (1mM)a 3.4 ± 0.5
Soluble Fraction 18’-MQ8 (2mM)a 3.6 ± 0.3
Soluble Fraction 18’-MQ8 (5mM)a 0.7 ± 0.1
1pMMO Specific Activity stated in units of nmol/minute/mg total protein ± S.E.M.
a5mM NADH was added as the reductant in these samples.
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diluted by membrane solubilization, leading to a decrease in pMMO activity.  With this
in mind, the experiments in Table 1 were performed in a similar fashion to those in
Chapter 3 to determine the effects of 18’-methylene CoQ8 on pMMO activity as
compared to previously published exogenous quinones.
Relative to formate and the two exogenous quinols (Table 1), the reduced form of
18’methylene CoQ8 performed poorly in vivo.  At low concentrations of 18’-MQ8H2,
pMMO exhibited only a small portion of the activity observed with formate or the
exogenous quinols.  Furthermore, the pMMO activity actually decreased with increasing
18’-MQ8 concentration, to the point of being undetectable at a concentration of 1mM
quinol.
The results for the membrane fraction were similar.  At low concentrations, 18’-
methylene CoQ8 supported low levels of pMMO activity.  In this case, however, the
activity increased with increasing quinol concentration, ultimately reaching a level
comparable to that observed with 5mM decyl-plastoquinol.  Duroquinol outperformed
18’-MQ8H2 as a reductant in the membrane fraction, supporting ~5-fold greater pMMO
activity. 
The endogenous quinone gave the most promising results when used as a
reductant for the solubilized form of pMMO.  Here, pMMO specific activity supported
by 18’-methylene CoQ8 attained a rate approximately three quarters of that observed in
the presence of decyl-plastoquinol.  The maximum rate was observed with 2mM
endogenous quinone and was significantly inhibited at higher concentrations of the
quinone (Table 1).  Interestingly, this inhibition has previously been observed with
duroquinol but not decyl-plastoquinol.
75
DISCUSSION
The respiratory chain of Methylococcus capsulatus remains poorly characterized.
The experiments described above were developed to identify an exogenous quinone(s)
which may serve as a vehicle for electron transfer reactions within the membrane of the
bacteria.  It had previously been shown that pMMO activity could be retained following
solubilization with lauryl maltoside only if quinones were present to provide reducing
equivalents (18).  Additionally, a novel quinone was isolated and identified by Green and
Collins (4) raising the possibility that this quinone could serve as a source of reducing
equivalents for pMMO, as is common in many bacterial respiratory chains (1,2,8). We
are also interested in potentially utilizing the endogenous quinone as a reducing source
during future purifications of the enzyme.
In addition to the quinone previously described by Collins and Green (18’-
methylene CoQ8) we have identified two other quinones within the membrane fraction of
M. capsulatus which had not previously been described; namely CoQ9 and 18’-methylene
CoQ9.  All quinones identified from the n-pentane extract in this study were ubiquinones.
Neither plastoquinones nor menaquinones were isolated.  This is consistent with previous
studies on the quinone content of methanotrophs (5,21).  The difference between our
results and those of Collins and Green could be attributed to either differences in the
solvent/purification scheme employed or the difference in growth conditions.  The
previous report detailed growth on a methane:air ratio of 50:50 at 30°C for 7 days.  In our
laboratory, we typically use a methane:air ratio of 20:80 at 42° - 45°C for a total period
of 2-3 days in the fermentor.  It has been reported that bacterial lipid content will vary
depending on growth temperature (10).
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The endogenous quinone, 18’-methylene CoQ8, was the focal point of
reconstitution studies due to the high amount present in the extract relative to the other
endogenous quinones.  Initial reconstitution experiments were attempted as an adaptation
of the method by Kurreck, et al. (12) in which the whole cell or membrane fraction is
sonicated in the presence of added quinol (reduced with sodium dithionite/sodium
borohydride in acidic methanol).  However, no activity was observed following use of
this method (data not shown).
Alternatively, the quinone was reduced and solvent evaporated to dryness under
vacuum and reincorporation was performed by gentle mixing with membranes as
previously reported for the detergent soluble fraction (Chapter 3).  The results from this
method also resulted in very low pMMO specific activity (Table 2).  However, it must be
noted that the quinol is extremely sensitive to oxidation since much of the quinol reverted
to the yellow color indicative of the oxidized quinone prior to addition of the enzyme
sample.  In part, this instability may explain the failure of the added quinol form of 18-
methylene CoQ8 to support pMMO activity.  Originally, it was thought that the greater
activity of duroquinol and decyl-plastoquinol resulted from their similarity in structure
and redox potential to quinols that would reduce pMMO in vivo.
The results of similar experiments with the membrane fraction did not show much
promise, either.  Again, only minimal activity was observed with the reduced form of the
endogenous quinol over the concentration range specified (Table 1).
The results for the detergent-solubilized membrane fraction, however, differ
greatly from those for the whole cell and membrane suspensions along with NADH.  In
this case, the endogenous quinone was added in its oxidized form to allow the
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endogenous reducing system to perform the task of quinone reduction.  Following
reincorporation of the endogenous quinone within the solubilized membrane fraction,
pMMO specific activity increased with increasing quinone concentration then became
inhibited at relatively high amounts (5mM).  Addition of the reduced form of the
endogenous quinol to the detergent solubilized fraction gave results similar to those with
whole cells and membranes.  This suggests that the instability of the synthetically
reduced endogenous quinol could be responsible for its inability to reduce pMMO in the
whole cell and membrane suspension samples.
 The specific activity attained with the endogenous quinone is approximately
three quarters of that attained with the reduced decyl-plastoquinol and higher than that of
exogenous duroquinol (Table 1).  It seems that the enzymatic activity of pMMO is
unaffected by the endogenous quinol until relatively high concentrations are achieved.
Analogous results have been observed with duroquinol and may be evidence of
competitive inhibition by the oxidized form of the quinone.  It has been reported that the
conformation of the isoprenyl chain relative to the semiquinone head may play a role in
the selectivity for quinones in the photosynthetic enzymes of bacteria and higher plants
(22).  Solubilization of pMMO by lauryl maltoside may result in conformational changes
to pMMO that render it more favorable for plastoquinol binding than for ubiquinol
binding.  Zheng, et al. reported that the isoprenyl CβCγ bond is coplanar with the
semiquinone ring in plastoquinone while that for ubiquinones is at a 90° angle with
respect to the ring (22).  Since duroquinol has no such C-C bond, it is conceivable that a
conformationally-altered pMMO would recognize it as being similar to decyl-
plastoquinol, with the “tail” (methyl group) being detected as planar.  It seems plausible
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that this sort of steric hindrance may play a role in the relative inability of ubiquinol
analogs to reduce solubilized pMMO in vitro.
Results with the oxidized 18’-methylene CoQ8 suggest addition of this cofactor
can overcome loss of quinone cofactors that occurs following solubilization. It appears at
least possible that a ubiquinone could be the mobile electron carrier responsible for the
reduction of pMMO.  This is further substantiated by the fact that neither plastoquinone
nor menaquinone were observed in the n-pentane extract from the lyophilized membrane
fraction.  Thus, it appears that the reduction of pMMO by exogenous quinols such as
decyl-plastoquinol and duroquinol is adventitious in nature.  Their high relative
hydrophobicity may enhance their ability to access the pMMO active site or surrounding
cofactors, resulting in non-specific reduction.
In conclusion, we have shown that an endogenous quinol present in high amounts
in M. capsulatus membranes can support solubilized pMMO specific activity in vitro,
suggesting that this cofactor may also be responsible for in vivo reduction, as well.
However, the data also suggest that it is not a good candidate for pMMO reduction during
purification due to its apparent ease of auto-oxidation in comparison to that of both decyl-
plastoquinol and duroquinol.  One of the latter two quinols (preferably decyl-
plastoquinol) still appears to be a better candidate for screening of pMMO activity during
future purifications as these quinols can be crystallized, precipitated and stored in
reduced form.  This is not the case for the endogenous ubiquinol.  Additionally, the latter
two are available commercially whereas 18’-methylene CoQ8 is not.
This data suggests that we change our present model of pMMO reduction in vivo.
It was previously hypothesized that a plastoquinol served as the reductant in vivo.
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However, the absence of any such quinones following organic solvent extraction as well
as the results obtained with 18’-methylene CoQ8 make us question this hypothesis.  The
ubiquinone isolated here is a potential reductant, yet it requires specific conditions in
which to exert its action.  It is still hypothesized that a dehydrogenase such as that
reported by Cook (6) reduces a quinone (likely 18’-methylene CoQ8) and these reducing
equivalents are subsequently transferred to pMMO, most likely in a direct fashion.
However, it must be noted that no experimental evidence for NDH-2-mediated reduction
of 18’-methylene CoQ8 exists at this time. Therefore, the earlier results by Smith and
Dalton (19) may still be explained by the hypothesis that lauryl maltoside either disrupts
a reductase to pMMO transfer or dilutes the quinone pool in a fashion which is overcome
by addition of quinone/quinol.
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CHAPTER FIVE
Oxygen Uptake Studies and Spectroscopic Kinetics
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INTRODUCTION
Oxidative phosphorylation is an important process in aerobic organisms, allowing
the organisms to harness energy by coupling oxidation of reduced cofactors to
phosphorylation of ADP, thereby producing an “energy currency” for individual cells.
The study of bacterial oxidative phosphorylation has required the development of cell-
free systems due to the impermeability of the outer membrane.  Unlike eukaryotic
systems, electron transport chains in bacteria are diverse due to the fact that there are
many different sources and acceptors of electrons used by the various organisms.
Additionally, the protein components can differ between organisms and, in some cases,
within the same organism, depending on growth conditions (2,5,6)
The key carbon component which undergoes oxidation for the release of energy in
M. capsulatus is methane.  The large amount of energy available upon oxidation of
methane is harnessed via an electron transport chain in methylotrophic bacteria (3).
These electron transport chains consist of dehydrogenases, iron-sulfur proteins, quinones,
cytochromes and cytochrome oxidases.  Little is known concerning the Fe-S proteins and
all quinones identified, to date, have been ubiquinones (12,24).
Among the aerobic methylotrophs, the chains do not appear to differ to a great
extent in the nature of components.  The three key differences are the presence or absence
of cytochrome c, the nature of the terminal oxidase(s) (type aa3 or o), and the branch
point to the alternative oxidases (2).  Another critical aspect of the methylotrophic
bacteria which must be kept in mind concerns methane oxidation: every molecule of
growth substrate (methane, in the case of M. capsulatus) is oxidized by way of methanol
dehydrogenase, including those that are eventually assimilated into cellular carbon.  This
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suggests the possibility that there could be an electron transport chain involved in
methanol oxidation that is separate from that involved in the oxidation of NADH (5).
Therefore, the knowledge gained with regards to methylotrophs will serve as a
foundation from which to approach our discussion of the methanotrophic M. capsulatus.
These ideas, in addition to what has been learned concerning eukaryotic mitochondria,
will form a basis for comparison of respiratory chain proteins.
In this chapter, we will turn our attention to proteins typically found in the latter
portions of respiratory chains.  In particular, we investigated the function of the
periplasmic methanol dehydrogenase, cytochrome c, and terminal oxidases.
Additionally, with regards to the apparent cytochrome b content of M. capsulatus, we
will investigate the possibility of the existence of a bc1-like complex.
Our initial model suggested that reducing equivalents from methanol entered the
respiratory chain of M. capsulatus at the level of cytochrome c.  This particular point was
hypothesized by Grozdev, et al  (1983) and subsequently shown to occur by Anthony, et
al. (4).  Methylococcus capsulatus has been shown to grow on both methane and
methanol, albeit at much slower rates when grown on the latter (25).  Therefore, it is of
interest to investigate this portion of the putative electron transport chain to either support
or refute this argument.
Also, proteins such as cytochrome c (8,14) and terminal oxidases have been
shown to be present in M. capsulatus (11), so the enzymatic activity of these enzymes
would be interesting to investigate, as well.  Our model 0depicts reducing equivalents
passing from a cytochrome c (received from either a bc1-like complex or methanol
dehydrogenase) to a terminal oxidase (most likely as that described by DiSpirito, et al.).
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RESULTS
The results in Table 1 detail the percent inhibition of oxygen uptake by several
well-characterized inhibitors of respiratory chains in other organisms.  The inhibition of
the background rates was measured with no added reductant.  As illustrated in Table 1,
the respiratory inhibitors piericidin A, amytal, rhein, HQNO, caffeine, myxothiazole,
antimycin A, and SHAM had no effect on the rate of oxygen uptake in membranes or
whole cells, regardless of the reductant.  These inhibitors were not used for further study.
The results observed for respiratory inhibition were very different when
potassium cyanide, octyl gallate, or both were used to inhibit oxygen uptake (Table1).
When analyzing the membrane fraction, cyanide, octyl gallate and the combination
proved to be inhibitory to oxygen uptake when background respiration was measured.
This background respiration is presumably dependent on endogenous substrates.  Each
inhibitor inhibited approximately half of the oxygen uptake when used alone while the
combination inhibited >90%.  When the exogenous reductant NADH was added to the
crude membrane preparation, each inhibitor again inhibited oxygen uptake by
approximately one-half while the combination abolished nearly all (95.4%) respiration
(Table 1).  When both inhibitors were used, the order of addition of inhibitor (cyanide vs.
octyl gallate), made no significant difference in the total amount of inhibition observed
(data not shown).
On the other hand, the results of inhibition by cyanide and octyl gallate were
different when analyzing the whole cell suspension (Table 1).  Background respiration
was completely abolished when either of the two inhibitors were used and identical
results were obtained when methanol was added as the exogenous substrate.  A small
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Table 1.  Effects of respiratory chain inhibitors on oxygen uptake in Methylococcus
capsulatus whole cells and membranes.
MEMBRANES WHOLE CELLS
basala + NADH basala + Formate +MeOH
Piericidin A (500µM) 0 0 0 0 0
Amytal (500µM) 0 0 0 0 0
Rhein (500uM) 0 0 0 0 0
HQNOb (1mM) 0 0 0 0 0
Caffeine (1mM) 0 0 0 0 0
Myxothiazole (500µM) 0 0 0 0 0
Antimycin A (500µM) 0 0 0 0 0
SHAM (3.5mM) 0 0 0 0 0
Cyanide (500µM) 52%a 58.4 ± 1.9 100 96.1 ± 0.7 100
Octyl Gallate (500µM) 58%a 56.2 ± 1.5 100 100 100
OG + CN- (500µM, each) 93%a 95.4 ± 0.8 n.d. n.d. n.d.
a Background respiration rate measured without added reductant.
b HQNO = 2n-heptyl-4-hydroxy-quinoline-N-oxide
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amount of residual activity remained when cyanide was used to inhibit oxygen uptake
with formate as the source of reducing equivalents, whereas all activity was abolished in
this system when octyl gallate was utilized (Table 1).
Oxygen uptake in the detergent-solubilized membrane fraction was observed with
NADH as reductant.  This was performed in an analogous manner to studies with
detergent-solubilized pMMO where quinone concentration of the system was
supplemented by an addition of exogenous quinone (Q0).  The data in Figure 1 depict the
oxygen uptake activity of a typical solubilized membrane preparation reduced with
NADH and supplemented with exogenous quinone.  The oxygen uptake activity was
minimal in the presence of NADH alone, but was dramatically enhanced following the
addition of the quinone in vitro.
In view of the interesting results obtained with the solubilized fraction, a similar
investigation of the unsolubilized membrane fraction was initiated.  The reduced forms of
the exogenous quinones Q0 and Q2 as well as the purified, endogenous 18’-methylene
CoQ8 were examined for their ability to increase oxygen uptake in the crude membrane
fraction.  All three quinols increased the rate of oxygen consumption above the basal rate
observed in membranes alone (data not shown).  The endogenous quinol had the smallest
effect of the three.  These oxygen uptake rates were about one-third that observed in the
solubilized fraction with Q0.  Octyl gallate inhibited oxygen uptake ~ 70-80% (Table 2)
while cyanide inhibited approximately 20-35% (Table 2) irrespective of the nature of the
quinol.
Reduction of the crude membrane fraction by the reduced form of cytochrome c
(from horse heart) increases oxygen uptake, as well (Figure 2).  500µM cyanide inhibited
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Figure 1.  Q0 stimulates oxygen uptake in the solubilized membrane fraction in the
presence of NADH.
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Table 2. Percent Inhibition of respiration in the membrane fraction by cyanide and octyl
gallate in the presence of exogenous and endogenous quinols.
Q0H2 Q2H2 18’-methylene CoQ8H2
Cyanide 21% 28% 35%
Octyl Gallate 79% 70% 78%
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Figure 2.  Reduced cytochrome c (horse heart) stimulates oxygen uptake in the
membrane fraction.  Cyanide inhibition detailed in A, octyl gallate effects shown in B.
92
57% of this rate, 655µM cyanide inhibited 72% and 1.3mM cyanide inhibited 93%
(Figure 2A).  Surprisingly, however, octyl gallate (in DMSO) actually increases this rate
by approximately 2-fold (Figure 2B).
To study the reduction of endogenous cytochrome c, the difference spectrum
(dithionite reduced – air oxidized) was established for isolated membranes (Figure 3).
The signal to noise ratio of the analogous spectrum in whole cells was unacceptable (data
not shown), so the reduction of cytochrome c555 was investigated only in the membrane
fraction.  As illustrated in Figure 4A, an increase in cytochrome c555 reduction was
observed when a solution of octyl gallate was added in methanol.  No increase in
absorbance was observed when the membrane fraction was boiled prior to analysis
(baseline trace, Figure 4A).  The initial velocity of the reaction increased with increasing
substrate concentration. Additionally, no increase was observed with methanol alone or
when the inhibitor/substrate mixture was added to buffer in the absence of membranes
(data not shown).  Similarly, when an aliquot of methanol was added to the same
preparation of membranes, an increase in cytochrome c555 reduction was observed in the
presence of cyanide (Figure 4B). However, the rate of this increase was dramatically
slower than that in the presence of octyl gallate (Figure 4).  Again, no increase in
absorbance was observed with a boiled membrane preparation (data not shown).
To ascertain the response of exogenous cytochrome c, the octyl gallate/methanol
solution was added to membrane preparations with varying amounts of horse heart
cytochrome c.  The amplitude of the response increased with increasing amounts of
cytochrome c, however, the initial rate of reduction was unaffected (Figure 5).
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Figure 3.  Dithionite-reduced minus air-oxidized difference spectrum for M. capsulatus
membrane fraction.  Note the absorbance at 555 nm, indicative of cytochrome c.
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Figure 4. A) Increasing amounts of methanol (0.1µL, 0.2µL, 0.3µL, 0.4µL, 0.5µL)
coincide with increased rates of cytochrome c555 reduction in membranes as measured by
increased abs @ 555nm.  Octyl gallate was included to prevent oxidation of cytochrome
c, thus allowing visualization of the absorbance increase.  The baseline trace is a result of
the addition to boiled membrane fraction.  B) Addition of methanol (0.5µL) to
membranes pre-incubated with potassium cyanide results in cytochrome c reduction at a
slower rate.
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Figure 5.   Amplitude of absorbance at 555 nm is a directly proportional to added
exogenous cytochrome c (horse heart).  Addition of octyl gallate in methanol at 1 minute.
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Finally, to examine the ability of quinols to reduce the endogenous cytochrome
c555, an aqueous solution of Q0H2  was added to a membrane preparation which had been
preincubated with solid octyl gallate.  As Figure 6 shows, a minimal increase in
absorption is observed when the quinol is used as a source of electrons with octyl gallate
used as inhibitor.  Similar results were obtained when the quinol was added to a
membrane preparation which had been preincubated with cyanide (data not shown).  A
range of quinol concentrations (50µM-1.0mM) were used, with no observable
cytochrome c reduction in any case.
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Figure 6.  Addition of 250µM Q0H2 to the membrane fraction does not result in
cytochrome c reduction, in the presence of octyl gallate.
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DISCUSSION
The data in Table 1 illustrate the effects of a variety of respiratory inhibitors on
oxygen consumption in both the membrane fraction (in vitro) as well as the whole cell
suspension (in vivo).  Most of the inhibitors had no effect.  For instance, additions of
rhein (17) and amytal (10,21) to respiring preparations (either membranes or whole cells)
exhibited no inhibition of oxygen uptake.  The data for amytal is somewhat inconsistent
with the results previously reported by Cook in which a ~50% decrease in NDH-2
activity was observed with additions of 250µM – 1.0 mM amytal (Cook, Ph.D.
dissertation).  However, those assays were performed on the purified dehydrogenase with
Q0 as the electron acceptor.  The NAD
+-linked dehydrogenase purified was described as
being mildly sensitive to amytal, however, no indication of that is observed here.  The
previous report mentioned that the amytal binding may have been non-specific (in view
of the high concentrations needed for inhibition), and therefore, physiologically
irrelevant.  Alternatively, there may be another path for electrons from either NADH
and/or formate (in whole cells) to oxygen, which is insensitive to amytal.  However, from
the data presented in this manuscript, it appears unlikely that a type 1 dehydrogenase
exists in M. capsulatus.
Also listed in Table 1 are the effects of caffeine and HQNO (21).  Neither of these
compounds affected respiration either.  One of the most potent inhibitors of type-1
NADH dehydrogenases, piericidin A (10,21), was also unable to inhibit oxygen uptake in
the two systems studied.  Typically, piericidin A need only be used at nM to pM
concentrations for complete inhibition in eukaryotic mitochondria.  Thus, this evidence,
along with evidence from the other NADH dehydrogenase inhibitors suggests that the
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only dehydrogenase found in M. capsulatus is of type 2, supporting Cook’s previous
conclusion.
Likewise, the data in Table 1 suggest that there is no bc1-like complex in M.
capsulatus.  In mitochondria, the bc1 complex is very sensitive to the inhibitors
myxothiazole and antimycin A at µM to nM concentrations (21)  It is also sensitive to
HQNO, although, to a lesser extent (21).  Here, no evidence for such a complex is
observed since neither antimycin A nor myxothiazole inhibited oxygen uptake in either
membranes or whole cells at the concentrations studied.  This contradicts previous
indications for the presence of such a complex, based on UV-vis absorption indicative of
cytochromes b.  These b-type cytochromes may correspond to the cytochromes
reportedly bound to pMMO after its purification (29).  Thus, our revised model does not
include such an enzyme within the respiratory chain.
The inhibitor known as SHAM (salicylhydroxamic acid) is an inhibitor of the
alternate oxidase found in some plants, bacteria, and trypanosomes (7,9,23).  However,
we see no evidence for oxygen uptake inhibition by SHAM within the membrane fraction
or the whole cell suspension of M. capsulatus.  Apparently, if there is another oxidase in
addition to the primary one, it is distinct from the SHAM-sensitive types found in plants,
bacteria, and trypanosomes.
Finally, inhibition of oxygen uptake was observed with two different inhibitors:
cyanide and octyl gallate.  Cyanide is a well-known inhibitor of terminal cytochrome c
oxidases while octyl gallate has recently been reported as an inhibitor of the alternate
oxidase in plants (1,15).  As Table 1 illustrates, either inhibitor was capable of reducing
oxygen uptake by approximately one-half (with NADH used as reductant) in the
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membrane fraction, and, when used in combination, the oxygen uptake was essentially
abolished (Table 1).  Interestingly, the oxygen uptake was inhibited completely in whole
cells by either inhibitor.  Furthermore, the background respiratory rate was inhibited in
vitro and in vivo in manners similar to that observed in the presence of exogenous
reductants (NADH, formate, and methanol).  This seems to suggest that these exogenous
reductants act in manners similar to the endogenous reductants responsible for basal
levels of respiration.
It has been shown by Anthony, et al. (4) that methanol dehydrogenase is capable
of using methanol to reduce a cytochrome cL in Methylobacterium extorquens, a
methylotroph.  A similar event was also hypothesized to exist for methanol
dehydrogenase and cytochrome cCO in M. capsulatus (12), and increased oxygen uptake
in whole cell suspensions following methanol addition is consistent with such a pathway.
This pathway from methanol, through methanol dehydrogenase to cytochrome c, and,
ultimately a terminal oxidase would likely involve an aa3-type oxidase such as that
reported by DiSpirito, et al. (11).  Such terminal oxidases are well known to be inhibited
by cyanide.
The site of inhibition of respiration by octyl gallate is still uncertain.  The
molecular mechanism of inhibition of the alternate oxidase by octyl gallate is not known.
Therefore, it is difficult to know which protein(s) this inhibitor is capable of binding in
M. capsulatus.  However, the molecular structure of octyl gallate is reminiscent of the
quinones, so it may compete with quinone binding sites.  However, none of the proteins
involved in methanol oxidation (methanol dehydrogenase, cytochrome c, cytochrome c557
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– cytochrome aa3 complex) have been reported to possess quinone binding sites, so the
mechanism of its inhibition of respiration from methanol is still a mystery.
If it competes with quinone binding, octyl gallate could be acting at points
between formate and the terminal electron acceptor, possibly with enzymes that obtain
reducing equivalents from quinols in vivo.  However, as mentioned above, no definitive
knowledge of octyl gallate’s interaction with proteins have been elucidated at the
molecular level.  Nonetheless, the data from the membrane fraction (Table 1) suggest that
M. capsulatus possesses two independent sites of O2 reduction.
Figure 1 illustrates the increase in oxygen uptake following an addition of
oxidized Q0 to detergent-solubilized membrane fractions.  This result suggests that (at
least) one of the oxygen reducing sites in M. capsulatus is capable of utilizing reducing
equivalents from quinones.
Table 2 illustrates the respiration of the membrane fraction (no detergent
solubilization) in the presence of Q0H2, Q2H2, and 18’-methylene CoQ8H2.  All three
quinols increased oxygen consumption in the membrane fraction, with the endogenous
quinol the least effective of the three (data not shown).  This result may be due to the
instability of the reduced form of 18’-methylene CoQ8 as described in Chapter 4.  Since
the quinol-linked respiration is sensitive to octyl gallate, and less so towards cyanide
(Table 2), the site of inhibition may be related to the alternate oxidase of higher plants
(1,15) which are also sensitive to octyl gallate.  However, we note that oxygen uptake is
only partially inhibited by either octyl gallate or cyanide when quinols are used as
reductants in vivo (Table 2).
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Figure 2 depicts the respiration of the membrane fraction (no detergent
solubilization) in the presence of the reduced form of cytochrome c.  The addition of
cytochrome c causes an increase in the oxygen uptake of the membrane preparation and
this is partially inhibited by additions of cyanide.  Up to 93% inhibition is achieved with
mM concentrations of cyanide.  In contrast, additions of octyl gallate increased the rate of
oxygen uptake in the membrane fraction by approximately two-fold (Figure 2).  This
result suggests two possible explanations: (1) the octyl gallate binds the same oxidase as
cyanide, increasing its enzymatic activity in some manner, or (2) octyl gallate binds to
another enzyme/protein in a manner which is inhibitory, thereby causing an increase in
the flux of reducing equivalents through the cytochrome c oxidase.  The former argument
seems unlikely since octyl gallate decreases oxygen consumption in vitro and in vivo in
the presence of NADH, formate and methanol.  The latter argument implies that there are
two pathways for reducing equivalents from cytochrome c to oxygen and that the
cyanide-sensitive pathway is preferred over the octyl gallate-sensitive pathway in vitro.
The results with whole cells presented in Table 1 do not appear to be consistent with the
two independent pathways for reducing equivalents to travel from cytochrome c to a
terminal oxidase.  However, it is possible that these pathways are coupled or linked in
some unknown way in whole cells and this coupling is disrupted upon cell lysis.  Clearly,
this is an area where further research is necessary to clarify these discrepancies.
To examine the effects of specific inhibitors on cytochrome c reduction,
difference spectroscopy was utilized to monitor reduction of cytochrome c555 as a
function of time.  The (dithionite reduced – air oxidized) difference spectrum was easily
observable for membrane preparations (Figure 3).  However, the analogous spectrum for
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the whole cell suspension was unacceptable for kinetic studies due to excessive noise.
Therefore, cytochrome c555 reduction was examined spectroscopically only in the
membrane fraction.
Figure 4 illustrates the effect of increasing concentrations of methanol on the
cytochrome c555 oxidation state in membrane preparations.  This increase in rate of
reduction occurred only when active enzyme and substrate were in the presence of octyl
gallate.  The concentration of octyl gallate was held constant as methanol concentration
was increased and the amplitude of the curves ultimately reached approximately the same
level though with increasing initial velocity (top panel).  This amplitude of the
absorbance could be increased as a function of added exogenous cytochrome c (Figure 5),
confirming that the absorbance change in Figure 4 is due to reduction of endogenous
cytochrome c.  This data shows that the rate of cytochrome c555 reduction is increased by
increasing amounts of methanol.  Similar results were obtained in the presence of
cyanide, but the relative rate of reduction was dramatically slower with equivalent
amounts of total protein (Figure 4).  Together, these results suggest the oxidation of
cytochrome c is inhibited by both octyl gallate and cyanide when methanol is available as
a substrate and that cyanide may also be inhibiting the reduction of cytochrome c by
methanol as well.
Finally, the effect of quinols on the oxidation state of cytochrome c was examined
with the reduced form of Q0 (Figure 6).  The results were not indicative of cytochrome c
reduction when either octyl gallate or cyanide were used to inhibit electron flow.  This
result suggests that reducing equivalents from quinols use a different pathway from that
involving cytochrome c.  This also suggests that the oxidase activity observed with the
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oxygen electrode in the presence of reduced quinols stems from activity of a quinol
oxidase, which is sensitive to octyl gallate.  The quinols would directly reduce such an
oxidase, increasing oxygen uptake.  Since the oxygen uptake in the membrane fraction in
the presence of reduced quinols is preferentially inhibited by octyl gallate, the enzyme
may resemble the alternate oxidase found in some higher plants.  However, it is distinct
from the latter in that it is not sensitive to SHAM.
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CHAPTER SIX
CONCLUSIONS
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This project investigated the respiratory chain of M. capsulatus (Bath) in addition
to some of the possible interactions of pMMO within this scheme (Figure 1).  Much of
what is known about the transfer of reducing equivalents in M. capsulatus (Bath) centers
on reactions involving pMMO.  In our laboratory, as well as others, copper ions have
been shown to stimulate pMMO activity both in vivo and in vitro.  Originally, it was
hypothesized that copper ions were in equilibrium with the aqueous environment and the
holoenzyme, resulting in the observed increase in pMMO activity upon addition of
copper ion (2).  Furthermore, recent reports have indicated that transcription of the 3.3kB
polycistronic mRNA (encoding pMMO) of M. capsulatus (Bath) was activated by copper
ions.  A similar event occurred in the methanotroph M. trichosporium OB3b.
Additionally, the gene transcription for the soluble form of the enzyme was repressed in
both methanotrophs upon addition of cupric ions.  Thus, pMMO activity appears to be
regulated by copper both post-transcriptionally and post-translationally (4).
Another question with regards to pMMO is the source of its reducing equivalents
in vivo.  It was previously assumed that NADH was the direct reductant of pMMO.
However, the decrease in pMMO activity in vitro following solubilization seemed to
contradict this theory because activity is poor when NADH is used as the reductant in this
system.  This could explain why earlier attempts at purifying pMMO have failed.  As we
have shown in Chapter 3, quinols can serve as electron donors to pMMO whereas NADH
is unable to support pMMO activity in the solubilized membrane fraction.  We suggested
that the quinone pool was diluted upon detergent solubilization, thereby decreasing the
rate of quinol-mediated reduction of pMMO.  This hypothesis was supported by data
which showed that pMMO activity could be recovered, following detergent
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solubilization, if the system were supplemented by exogenous quinols.  Furthermore, data
by Cook and Shiemke suggest that a type 2 NADH dehydrogenase may be responsible
for reducing quinones in vivo, providing a link in the chain responsible for the transport
of reducing equivalents from NADH to pMMO.  Furthermore, following solubilization,
pMMO retained characteristics of the membrane-bound form in that it was still
stimulated by copper ion supplementation, inhibited by the chelator EDTA, inactivated
by acetylene, and radiolabeled on the 26kDa polypeptide (2).
Given the possibility that a quinol could serve as an electron donor for pMMO in
vivo, we set out to examine the endogenous quinones of M. capsulatus (Bath) to
determine if they could mimic the action of the exogenous quinols utilized in Chapter 3
(duroquinol and decyl-plastoquinol).  We isolated, purified, and characterized quinones
similar to those previously reported by Collins & Green (1985), with the exception that
our cultures produced two quinones which had not previously been observed (CoQ9 and
18’-methylene CoQ9). The dominant species (18’-methylene CoQ8) was capable of
enhancing pMMO activity in solubilized membrane fractions but only when added in the
oxidized form in combination with NADH.  This data, in combination with the fact that
no other type of quinone was identified (nor has previously been observed) suggests that
18’-methylene CoQ8 is the mobile electron carrier in the membrane of M. capsulatus
which donates reducing equivalents to pMMO.
Finally, classical inhibitor studies and spectroscopy have allowed us to formulate
some hypotheses and/or conclusions with respect to other proteins in the respiratory chain
of M. capsulatus.  First of all, both in vitro and in vivo oxygen uptake studies with the
oxygen electrode argue against the existence of either a type-1 NAD+-linked
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dehydrogenase (consistent with Cook’s results) or a bc1-like complex.  Secondly, there
appears to be a second (alternate) oxidase activity in vitro (supporting Anthony’s
previous proposal (1)).  This oxidase is distinct from the cyanide-sensitive oxidase and
seems to be insensitive to SHAM, yet sensitive to octyl gallate.  The octyl gallate-
sensitive oxidase may obtain reducing equivalents primarily from quinols.  Also, there
could potentially be more than these two types of oxidases in the respiratory chain, but
further studies need to be performed to elucidate this.  Additional insight could also be
gained from studying the effects of the quinone redox state (quinone:quinol ratio) as well
as the effects of keto acids, since some species of bacteria and plants have alternate
oxidases sensitive to one or the other of these factors (5,6).
Furthermore, it is apparent that an endogenous c-type cytochrome is capable of
accepting reducing equivalents (probably from methanol dehydrogenase) when methanol
is added as a substrate in vitro and in vivo.  Electron flow can be blocked by either octyl
gallate or cyanide (to a lesser extent) at a point beyond cytochrome c reduction,
suggesting that both inhibitors are capable of inhibiting electron flow to a terminal
oxidase.  Zahn, et al. (7) alluded to the possibility of a cytochrome c reducing pMMO,
however, there is no data to support this possibility.  Furthermore, some of the
interactions studied in vitro (following cell lysis) may be non-physiological in nature,
thus, the in vivo results are more biologically relevant
In the future, several avenues could be explored.  Purification of pMMO should
probably be explored using exogenous quinols as electron donors (most notably, decyl-
plastoquinol) in solubilized fractions.  For the past few years, the research in this
laboratory has suggested that quinone pool dilution by detergent could be the key
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shortcoming in past attempts at protein purification.  This type of method may also
overcome the extreme conditions under which the recent “purifications” had to be
performed (anaerobic environments, etc.) (3,7).
Further isolation and purification of the secondary oxidase activity found in vitro
could be investigated.  It seems odd that an additional activity has been observed in vitro
that is not apparent in vivo, so purification of this activity from the membrane fraction, as
well as subsequent sequence analysis of the entity, may help clarify the respiratory chain
of M. capsulatus (Bath).
Additionally, more detailed investigations of pMMO and/or membrane-bound
oxidase interactions with the endogenous quinones could be noteworthy.  Resuspension
of these proteins in phospholipid vesicles along with the quinol counterparts may lead to
insights not practical in crude membrane preparations or detergent-solubilized fractions.
This route may also lead to more relevant results in spectroscopic analyses, steering clear
from the potential problems with organic solvents mentioned here.
Thus, it appears that a foundation for the respiratory chain of Methylococcus
capsulatus (Bath) has been outlined, but much work remains to be performed.
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Figure 1.  Respiratory Chain Model of M. capsulatus
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FUTURE WORK
It is advised that continuing research on this project concentrate on the following
five areas:
(i) investigation of oxiadase activities with higher concentrations of cyanide
(ii) purification of the putative alternative oxygen consumer
(iii) purify pMMO with the decyl-plastoquinol as the reducing source
(iv) extension of studies with DMSO as substrate
(v) reconstitution of NDH-2 with the endogenous quinol
The investigations performed here suggested that cyanide does not exert the
impact of inhibition of oxygen consumption to the extent that octyl gallate was capable.
However, the concentrations of cyanide used here may not be sufficient to provide
suffiicient insight.  It was later discovered that concentrations as high as 5mM are
typically used to inhibit alternative oxidases in some species.
If it is concluded, unequivocally, that an alternative oxidase exists, purification of
this protein would provide more insight into the respiratory function of the chain.  Many
species contain alternative oxidases which possess simpler subunit stoichiometries than
that of the primary oxidase.  Following purification, sequencing anlysis could provide
information to formulate a 3-dimensional model of the enzyme and suggest potential
substrate binding sites, as well as conserved amino acids.
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As supported by evidence in two different chapters within this manuscript, decyl-
plastoquinol may serve as a suitable alternate reductant during purification of pMMO.
As mentioned many times, the past failures of pMMO purification may have been the
result of dissociation of essential subunits and/or cofactors.  If quinols are capable of
direct reduction of pMMO (decyl-plastoquinol being the best candidate from this work),
then purification with such a substrate should prove useful during in-process analyses.
DMSO was curiously capable of reducing cytochrome c when octyl gallate was
used as an inhibitor, but not when cyanide was utilized.  However, DMSO showed no
apparent increase in oxygen uptake with the oxygen electrode in either the membrane
fraction or whole cells.  This seems very puzzling an surely requires more investigation
and a different series of experiments.  One species of methylotroph has been shown to
metabolize DMSO as a substrate, but evidence for this has not been shown for M.
capsulatus to date.
Finally, reconstitution of NDH-2 with endogenous quinone could provide
evidence for the interaction of the reductase with endogenous lipids suitable for
subsequent reduction of pMMO.  Cook, et. al. attempted such an experiment, but only
one concentration was investigated.  A series of concentrations may provide a better
understanding of the true interactions in vivo.
